Overview of bone mineral density in postmenopausal women

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 47, Issue 1 SUPPL., 2002, Pages 71-81

  Notelovitz, Morris ^a  

^a NONE   (United States)

Author keywords

Androgens, synthetic; Bone mineral density; Postmenopausal osteoporosis; Postmenopause

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTACID AGENT; ANTICONVULSIVE AGENT; CORTICOSTEROID; ESTROGEN; ESTROGEN RECEPTOR; HYDROCORTISONE; PREDNISONE; SEX HORMONE; STEROID; THIAZIDE DIURETIC AGENT; THYROID HORMONE;

BONE DENSITY; BONE DEVELOPMENT; BONE MINERAL; DIET; DRUG BIOAVAILABILITY; DRUG INDUCED DISEASE; EXERCISE; FEMALE; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; NUTRITION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RACE; REVIEW; RISK FACTOR;

EID: 0036155742     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995
2. Effect of alendronate on risk of fracture in women with low bone mineral density but without vertebral fractures
3. NIH concensus statements: 111. Osteoporosis prevention, diagnosis, and therapy
4. Epidemiology of fractures of the proximal femur in Rochester, Minnesota
5. Epidemiology of vertebral fractures in women
6. Androgens directly stimulate proliferation of bone cells in vitro
7. Calcitonin, estrogens and the bone
8. Effects of dihydrotestosterone on bone biochemical markers in sham and oophorectomized rats
9. Estrogen therapy and osteoporosis: Principles and practice
10. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
11. Transforming growth-factor Beta gene family members and bone
12. Regulation of interleukin-6 osteogenesis and bone mass by androgens: The role of the androgen receptor
13. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study
14. Sex steroids, bone mass, and bone loss: A prospective study of pre-, peri-, and postmenopausal women
15. Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: Associations with sex hormone-binding globulin, estradiol, and estrone levels
16. Rate of bone loss is associated with mortality in older women: A prospective study
17. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women
18. Sex steroid hormones, bone mineral density, and risk of breast cancer
19. Bone mineral density and breast cancer risk in postmenopausal women
20. Association between breast cancer and bone mineral density: The Dubbo Osteoporosis Epidemiology Study
21. Bone mineral density and risk of breast cancer: Differences by family history of breast cancer: Study of Osteoporotic Fractures Research Group
22. Osteoporotic fractures due to osteoporosis: Impacts of a frailty pandemic in an aging world
23. Prediction of osteoporotic fractures by bone densitometry and COLIA1 genotyping: A prospective, population-based study in men and women
24. The epidemiology and pathogenesis of osteoporosis
25. Osteoporosis: A worldwide problem?
26. Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women
27. Epidemiology of fractures in North America
28. A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women
29. Pathophysiology of bone loss
30. Body height and hip fracture: A cohort study of 90,000 women
31. Genetic factors in determining bone mass
32. Genetic determinants of bone mass in adult women: A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates
33. Genetic determinants of bone mass in adults: A twin study
34. The changing relative importance of genetics and environment in adult women
35. A familial risk profile for osteoporosis
36. Associations between maternal peak bone mass and bone mass in prepubertal male and female children
37. Hysterectomy surveillance - United States, 1980-1993
38. The hormonal activity of the postmenopausal ovary
39. Bone mineral density in women with asthma on long-term inhaled corticosteroid therapy
40. Metabolic bone disease
41. Risk factors for hip fracture in Caucasian women: Study of Osteoporotic Fractures Research Group
42. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly
43. Oligo-amenorrheic long-distance runners may lose more bone in spine than in femur
44. Predictors of bone mineral density reduction in adolescents with anorexia nervosa
45. Depression: A major, unrecognized risk factor for osteoporosis?
46. Reduced spinal bone mineral density in adolescents of an ultra-orthodox Jewish community in Brooklyn
47. Relation of early menarche to high bone mineral density
48. Bone gain in young adult women
49. Critical years and pubertal stages for spinal and femoral bone mass accumulation during adolescence
50. How do reproductive and lifestyle factors influence bone density in distal and ultradistal radius of early postmenopausal women? The Nord-Trondelag Health Survey, Norway
51. Testosterone deficiency in women
52. Osteoporosis due to androgen deprivation therapy in men with prostate cancer
53. Osteoporosis after orchiectomy for prostate cancer
54. Responses of bone cells to biomechanical forces in vitro
55. Mechanical strain as well as estrogen activates estrogen receptor alpha in bone cells
56. Effects of estrogen replacement therapy on hip structural geometry
57. Lean mass and physical activity as predictors of bone mineral density in 16-20-year-old women
58. Relative influence of physical activity, muscle mass and strength on bone density
59. Lifetime leisure exercise and osteoporosis: The Rancho Bernardo study
60. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures: A randomized controlled trial
61. Effects of physical activity on bone mineral content and muscle strength in women: A cross-sectional study
62. Walking is related to bone density and rates of bone loss
63. Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women
64. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women
65. Vitamin D3 and calcium to prevent hip fractures in elderly women
66. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
67. Low dose estrogen and calcium have an additive effect on bone resorption in older women
68. The role of calcium in peri- and postmenopausal women: Consensus opinion of the North American Menopause Society
69. What strategies can women use to optimize bone health at this stage of life?
70. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women
71. Calcium bioavailability and its relation to osteoporosis
72. Effect of soy protein on bone metabolism in postmenopausal Japanese women
73. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women
74. Isoflavones and postmenopausal bone health: A viable alternative to estrogen therapy?
75. Vitamin K intake and hip fractures in women: A prospective study
76. Nutrition, osteoporosis, and aging
77. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture
78. Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women
79. Is caffeine associated with bone mineral density in young adult women?
80. Cigarette smoke inhibits osteogenic differentiation and proliferation of human osteoprogenitor cells in monolayer and three-dimensional collagen gel culture
81. Smoking, antioxidant vitamins, and the risk of hip fracture